New Clinical Trials for Constipation

Enroll in a Clinical Trial for ConstipationConstipation is a condition that is seen in both adults and children. Many children suffer from it at times during their life when their diet is changing drastically, such as going on solid foods for the first time. Although constipation clinical research shows that the majority of adult constipation can be treated in non-medical ways, it is still an important condition to research and study. We are always in search of new ways of preventing, managing and treating the worst symptoms of constipation.

Current constipation clinical trials are listed on this page. If you or someone you know suffers from constipation on a regular basis, you may be eligible to participate in one of these studies.

What is Constipation?

Constipation is a symptom of problems with bowel movements being difficult to pass. This is usually caused either by an obstruction in the intestines or rectum, or by what is called colonic slow transit. Colonic slow transit is slow movement of the bowels due to diet and hormones. Constipation is also known as costiveness, dyschezia and dysynergic defecation. Constipation also refers to infrequent bowel movements, the need to strain during bowel movements or feelings of incomplete bowel movements. Constipation can become chronic and this is known as irritable bowel syndrome.

Constipation Treatments

Constipation treatments include diet changes, laxatives, enemas, biofeedback, and surgery. Since constipation is often caused by a lack of fiber or fluids, eating more fiber and increasing fluids will often take care of the problem. A permanent change in diet can also usually prevent the constipation from returning. Laxatives are not encouraged for treating constipation since people can become dependent on them. Enemas can be helpful, but they only remove stool from the rectum. If all else fails, physical removal of the bowel movement by a physician may be necessary.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
904 Constipation
clinical trials

Gastroenterology Clinical Trial
Constipation Clinical Trial
Status: Enrolling
Updated: 1/1/1970
mi
from
DeLand, FL
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
mi
from
Tampa, FL
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Kingsport, TN
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Tampa, FL
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Castle Rock, CO
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Dayton, OH
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Encinitas, CA
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Huntsville, AL
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Laurel, MD
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Longview, TX
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Mobile, AL
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Paw Paw, MI
Click here to add this to my saved trials
Gastroenterology, Musculoskeletal, Nephrology / Urology, Psychiatry / Psychology, Other Clinical Trial
Clinical Efficacy of Changing the InterStim® Parameters in Patients With Interstitial Cystitis/Painful Bladder Syndrome
Status: Enrolling, Phase IV
Updated: 4/28/2014
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Constipation Clinical Trial
Phase 2 Study to Evaluate Safety and Efficacy of RM-131 Administered to Patients With Chronic Constipation
Status: Enrolling, Phase II
Updated: 11/26/2013
mi
from
Rochester, MN
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Constipation Clinical Trial
Status: Enrolling
Updated: 1/1/1970
mi
from
Port Orange, FL
Click here to add this to my saved trials
Constipation Clinical Trial
A Safety and Efficacy Evaluation of BLI801 Laxative in Constipated Adults
Status: Enrolling
Updated: 9/14/2012
mi
from
Germantown, TN
Click here to add this to my saved trials
Opioid-Induced Constipation Clinical Trial
Long Term Safety of Naldemedine
Status: Enrolling, Phase III
Updated: 11/19/2013
mi
from
Atlanta, GA
Click here to add this to my saved trials
Opioid-Induced Constipation Clinical Trial
Long Term Safety of Naldemedine
Status: Enrolling, Phase III
Updated: 11/19/2013
mi
from
Bellevue, WA
Click here to add this to my saved trials
Opioid-Induced Constipation Clinical Trial
Long Term Safety of Naldemedine
Status: Enrolling, Phase III
Updated: 11/19/2013
mi
from
Boise, ID
Click here to add this to my saved trials
Opioid-Induced Constipation Clinical Trial
Long Term Safety of Naldemedine
Status: Enrolling, Phase III
Updated: 11/19/2013
mi
from
Greer, SC
Click here to add this to my saved trials
Opioid-Induced Constipation Clinical Trial
Long Term Safety of Naldemedine
Status: Enrolling, Phase III
Updated: 11/19/2013
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Gastroenterology Clinical Trial
A Lactation Study in Women Who Are Breastfeeding or Pumping and Are Receiving Linaclotide Therapeutically
Status: Enrolling, Phase I
Updated: 9/2/2015
mi
from
Iowa City, IA
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling, Phase II
Updated: 1/12/2016
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling, Phase II
Updated: 1/12/2016
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling, Phase II
Updated: 1/12/2016
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling, Phase II
Updated: 1/12/2016
mi
from
San Antonio, TX
Click here to add this to my saved trials
Constipation - Functional Clinical Trial
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling, Phase III
Updated: 2/29/2016
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Constipation - Functional Clinical Trial
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling, Phase III
Updated: 2/29/2016
mi
from
Kansas City, MO
Click here to add this to my saved trials
Constipation - Functional Clinical Trial
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling, Phase III
Updated: 2/29/2016
mi
from
Longview, TX
Click here to add this to my saved trials
Constipation - Functional Clinical Trial
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling, Phase III
Updated: 2/29/2016
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Constipation - Functional Clinical Trial
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling, Phase III
Updated: 2/29/2016
mi
from
Fayetteville, AR
Click here to add this to my saved trials
Constipation - Functional Clinical Trial
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling, Phase III
Updated: 2/29/2016
mi
from
Nashville, TN
Click here to add this to my saved trials
Constipation - Functional Clinical Trial
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling, Phase III
Updated: 2/29/2016
mi
from
Orange City, FL
Click here to add this to my saved trials
Constipation - Functional Clinical Trial
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling, Phase III
Updated: 2/29/2016
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Constipation - Functional Clinical Trial
Efficacy and Safety of Lubiprostone in Pediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling, Phase III
Updated: 2/29/2016
mi
from
Jackson, MS
Click here to add this to my saved trials
Constipation - Functional Clinical Trial
Efficacy and Safety of Lubiprostone in Pediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling, Phase III
Updated: 2/29/2016
mi
from
Longview, TX
Click here to add this to my saved trials
Constipation - Functional Clinical Trial
Efficacy and Safety of Lubiprostone in Pediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling, Phase III
Updated: 2/29/2016
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Constipation - Functional Clinical Trial
Efficacy and Safety of Lubiprostone in Pediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling, Phase III
Updated: 2/29/2016
mi
from
Miami, FL
Click here to add this to my saved trials
Constipation - Functional Clinical Trial
Efficacy and Safety of Lubiprostone in Pediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling, Phase III
Updated: 2/29/2016
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Constipation - Functional Clinical Trial
Efficacy and Safety of Lubiprostone in Pediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling, Phase III
Updated: 2/29/2016
mi
from
Amarillo, TX
Click here to add this to my saved trials
Constipation - Functional Clinical Trial
Efficacy and Safety of Lubiprostone in Pediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling, Phase III
Updated: 2/29/2016
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Constipation - Functional Clinical Trial
Efficacy and Safety of Lubiprostone in Pediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling, Phase III
Updated: 2/29/2016
mi
from
Orange City, FL
Click here to add this to my saved trials
Constipation - Functional Clinical Trial
Efficacy and Safety of Lubiprostone in Pediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling, Phase III
Updated: 2/29/2016
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Constipation - Functional Clinical Trial
Efficacy and Safety of Lubiprostone in Pediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling, Phase III
Updated: 2/29/2016
mi
from
Tacoma, WA
Click here to add this to my saved trials
Functional Constipation in Children Ages 6-17 Years Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
Status: Enrolling, Phase II
Updated: 3/31/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Functional Constipation in Children Ages 6-17 Years Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
Status: Enrolling, Phase II
Updated: 3/31/2016
mi
from
Boston, MA
Click here to add this to my saved trials
Functional Constipation in Children Ages 6-17 Years Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
Status: Enrolling, Phase II
Updated: 3/31/2016
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Functional Constipation in Children Ages 6-17 Years Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
Status: Enrolling, Phase II
Updated: 3/31/2016
mi
from
Dayton, OH
Click here to add this to my saved trials
Functional Constipation in Children Ages 6-17 Years Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
Status: Enrolling, Phase II
Updated: 3/31/2016
mi
from
Homestead, FL
Click here to add this to my saved trials
Functional Constipation in Children Ages 6-17 Years Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
Status: Enrolling, Phase II
Updated: 3/31/2016
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Functional Constipation in Children Ages 6-17 Years Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
Status: Enrolling, Phase II
Updated: 3/31/2016
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Functional Constipation in Children Ages 6-17 Years Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
Status: Enrolling, Phase II
Updated: 3/31/2016
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Functional Constipation in Children Ages 6-17 Years Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
Status: Enrolling, Phase II
Updated: 3/31/2016
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 3/31/2016
mi
from
Miami, FL
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 3/31/2016
mi
from
Providence, RI
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 3/31/2016
mi
from
Raleigh, NC
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 3/31/2016
mi
from
San Francisco, CA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Open-Label, Long-term Study to Assess the Immunogenicity of Linaclotide Administered Orally to Adult Patients With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation
Status: Enrolling, Phase IV
Updated: 3/31/2016
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Open-Label, Long-term Study to Assess the Immunogenicity of Linaclotide Administered Orally to Adult Patients With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation
Status: Enrolling, Phase IV
Updated: 3/31/2016
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Open-Label, Long-term Study to Assess the Immunogenicity of Linaclotide Administered Orally to Adult Patients With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation
Status: Enrolling, Phase IV
Updated: 3/31/2016
mi
from
Flint, MI
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Open-Label, Long-term Study to Assess the Immunogenicity of Linaclotide Administered Orally to Adult Patients With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation
Status: Enrolling, Phase IV
Updated: 3/31/2016
mi
from
Fresno, CA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Open-Label, Long-term Study to Assess the Immunogenicity of Linaclotide Administered Orally to Adult Patients With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation
Status: Enrolling, Phase IV
Updated: 3/31/2016
mi
from
Iowa City, IA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Open-Label, Long-term Study to Assess the Immunogenicity of Linaclotide Administered Orally to Adult Patients With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation
Status: Enrolling, Phase IV
Updated: 3/31/2016
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Open-Label, Long-term Study to Assess the Immunogenicity of Linaclotide Administered Orally to Adult Patients With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation
Status: Enrolling, Phase IV
Updated: 3/31/2016
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Open-Label, Long-term Study to Assess the Immunogenicity of Linaclotide Administered Orally to Adult Patients With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation
Status: Enrolling, Phase IV
Updated: 3/31/2016
mi
from
Tucson, AZ
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Open-Label, Long-term Study to Assess the Immunogenicity of Linaclotide Administered Orally to Adult Patients With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation
Status: Enrolling, Phase IV
Updated: 3/31/2016
mi
from
Watertown, MA
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Duarte, CA
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Little Rock, AR
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Charleston, SC
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Tucson, AZ
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Worcester, MA
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
mi
from
Beaumont, TX
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
mi
from
Bradenton, FL
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
mi
from
Clearwater, FL
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
mi
from
Concord, NC
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
mi
from
Egg Harbor Township, NJ
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
mi
from
El Cajon, CA
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
mi
from
Encinitas, CA
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
mi
from
Oceanside, CA
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
mi
from
Sacramento, CA
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
mi
from
Stamford, CT
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Huntsville, AL
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Atlanta, GA
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Foothill Ranch, CA
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Jackson, MS
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Kansas City, KS
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Ogden, UT
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Peoria, AZ
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Waukesha, WI
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Woodstock, GA
Click here to add this to my saved trials
1 2 3 4 5 6 7 8 9